Cornerstone Therapeutics to Host Third Quarter 2010 Conference Call
CARY, N.C., Oct. 28 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq: CRTX) today announced that it will host a conference call at 4:30 PM ET on Thursday, November 4, 2010, to discuss its financial results for the quarter and nine months ended September 30, 2010. Financial results are expected to be released on Thursday, November 4, 2010, after the capital markets close.
To participate in the live conference call, please dial 866-804-6927 (U.S. callers) or 857-350-1673 (international callers), and provide passcode 19358387. A live webcast of the call will also be available through the Investor Relations section of the Company's website. Please allow extra time prior to the webcast to register, download and install any necessary audio software.
The conference call and the webcast will be archived for 30 days. The telephone replay of the call will be available at 7:30 PM ET on November 4, 2010 by dialing 888-286-8010 (U.S. callers) or 617-801-6888 (international callers), and providing passcode 43083287.
About Cornerstone TherapeuticsCornerstone Therapeutics Inc. (Nasdaq: CRTX), headquartered in Cary, N.C., is a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets. The Company currently promotes multiple marketed products in the United States to respiratory-focused physicians, key retail pharmacies and hospitals with its specialty sales forces. The Company also has a late-stage clinical pipeline with a recent regulatory submission filing and four additional regulatory approval submissions targeted within the next three years. Key elements of the Company's strategy are to in-license or acquire rights to underpromoted, patent-protected, branded respiratory or